Lately, our group has proposed CypC levels >17.5 pg/mL as a new biomarker of CAD and has described its correlation with cardiovascular risk factors (Alfonso et al., 2019; Bayon et al., 2020; Bayon et al., 2021). Here, PPIC is linked to coronary artery disorder.